longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Sito Bio

300583

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 249.97, above the reasonable range, cheaper than 0.77% of the time in the past 5 years, and the industry ranks 158/221, the industry Median 23.00.

249.97xP/E
¥12.87Stock price
¥0.05Earnings per share
249.97xP/E
Stock price¥12.87Earnings per share¥0.05

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
43.44x
Typical range
-50.97x–63.42x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.00x
063126189252

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.00x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600518SHKMYY
647.76x--¥19.08B
000766SZTONGHUA GOLDEN-HORSE
630.91x--¥15.51B
300026SZChase Sun
535.44x1,300.00%¥9.61B
603439SHSanli Pharmaceutical
13,532.74x1,190.91%¥5.06B
002688SZJinhe Biotechnology
213.71x749.86%¥4.39B
002923SZRundu Pharma
264.49x--¥3.56B
301111SZLSPG
549.73x--¥3.26B
600671SHTMSP
200.52x--¥2.74B
300583SZSito Bio
249.97x--¥2.44B
301258SZFUSHILAI
339.14x--¥2.24B
002873SZXintian Pharma
243.90x--¥2.00B
301130SZXDYY
336.14x--¥1.98B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.